Notorious RSV

• 2024

  Log in to bookmark this resource.

  Log in
• Dennis Ren

---

Access Resources

• InterviewEN
• Ask aRCie About This Resource

About

This "Ready. Prep. Go! Podcast" features a conversation with Daniel Dodson, MD, MS, a pediatric infectious disease specialist, highlighted the need for strategic allocation of the limited supply of nirsevimab to high-risk infants, which led to challenging decisions and emotional appeals from caregivers during last year's simultaneous rise in cases of COVID, influenza, and RSV.

---

Tags

Focus Area: Infectious Disease

Keywords: Critical Care; Hospitals, Pediatric; Respiratory Syncytial Viruses; Alphainfluenzavirus; Betainfluenzavirus; COVID-19

Emergency Management Stages: Mitigation; Preparedness (Prevention / Protection)

Audiences: Emergency Managers; Nurses; Physicians; Public Health Professionals

Format: Interview

Media Type: Podcast

Institutions: Pediatric Pandemic Network (PPN)

Institution Type: Non-Governmental Organization

Language: English

Bundles: Ready. Prep. Go! Podcast

---

More like this

A Global Connection 2024 · Pediatric Pandemic Network (PPN) Notorious RSV 2024 · Pediatric Pandemic Network (PPN) Pediatric Respiratory Virus Surge Response - Fall/Winter 2022-23 2023 · Pediatric Pandemic Network (PPN)

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---